Logo

American Heart Association

  9
  0


Final ID: TP311

Immune Checkpoint Inhibitors and Stroke Etiology in a Retrospective Cohort of Patients with Non-Small Cell Lung Cancer

Abstract Body: Introduction:
Immune Checkpoint Inhibitors (ICIs) used for treatment of malignancies might promote atherosclerosis and increase the risk of ischemic stroke (IS). We aimed to compare IS characteristics of patients with non-small cell lung cancer (NSCLC) who received ICIs compared to those who did not. We hypothesized that IS associated with atherosclerosis will be more common among those treated with ICIs than other treatments.
Methods:
A retrospective single center study of patients,18 or older, with NSCLC presenting between 2013 and 2023, treated with either ICIs, chemotherapy, or a combination and had an IS any time following treatment. Patients without vessel imaging were excluded. We collected demographics and stroke characteristics. Two sample Mann-Whitney U and chi-square test were used to compare demographics and stroke etiologies among patients who received chemotherapy and those who received ICIs with or without chemotherapy.
Results:
A total of 58 patients were identified, 22 received chemotherapy only and 36 received ICIs. The mean age was 68.8, with 50% male (29/58). ICI treated groups had significantly more stage IV diagnoses (chemotherapy only 3.6%, ICI 67%, p=0.04). There was no difference in median time from treatment to stroke onset in days between groups; chemotherapy 90.5 (range 27-386) vs. ICI 337.5 (range 95-665), p= 0.39. The stroke etiology in those treated with chemotherapy alone were as follows: Large artery atherosclerosis (3), cardioembolic (8), small vessel disease (5), ESUS (5), other (1). For those treated with either ICI alone or ICI and chemotherapy: Large artery atherosclerosis (5), cardioembolic (6), small vessel disease (2), ESUS (23), other (0). Stroke etiology consistent with embolic stroke with unknown source (ESUS) was more common in the ICI group (chemotherapy only 2.3%, ICI 64%, p=0.02).
Conclusions:
Contrary to prior research suggesting atherogenesis with ICI, the most common stroke etiology in the ICI group was ESUS.
  • Handshoe, Jonathan  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Coors, Benjamin  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Khorana, Alok  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Uchino, Ken  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Ibrikji, Sidonie  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Author Disclosures:
    Jonathan Handshoe: DO NOT have relevant financial relationships | Benjamin Coors: No Answer | Alok Khorana: DO have relevant financial relationships ; Consultant:Anthos:Active (exists now) ; Consultant:Pfizer:Past (completed) ; Consultant:BMS:Past (completed) ; Consultant:WebMD:Active (exists now) ; Consultant:Sanofi:Past (completed) ; Consultant:Regeneron:Active (exists now) | Ken Uchino: DO have relevant financial relationships ; Consultant:Evaheart, Inc.:Active (exists now) | Sidonie Ibrikji: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Risk Factors and Prevention Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
A single-cell lung atlas of human pulmonary arterial hypertension

Dai Zhiyu, Yi Dan, Zhao Hanqiu, Hong Jason, Fallon Michael

A 3-Year, Pre-Trial, Real-world Data Analysis of Patients Enrolled in VICTORION-INITIATE: Insights Using Tokenization

Rodriguez Fatima, Cosmatos Irene, Desai Nihar, Wright R, Ross Elsie, Ali Yousuf, Kumar Biswajit, Han Guangyang, Cai Beilei, Abbas Cheryl, Ryan Amy

More abstracts from these authors:
Comparing Study Designs and Statistical Methods in Mechanical Thrombectomy Trials in Ischemic Stroke: A Systematic Review

Gulati Akanksha, Griffin Kim, Perez Malagon Carlos David, Gulati Yudhister, Bharti Anandita, Harnegie Mary Pat, Cho Sung-min, Uchino Ken

Assessing the Ability of ChatGPT to Guide the Decision for Intravenous Thrombolysis in Patients with Acute Ischemic Strokes

Ibrikji Sidonie, Uchino Ken, Buletko Andrew, Itrat Ahmed, Sundararajan Jayashree, Kharal Abbas, Al Banna Mona, Khawaja Zeshaun

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)